Anxiety
Conditions
Interventions
Single dose trial: 30 healthy subjects ingesting 500 mg dry extract capsule whole plant Passiflora incarnata L.
Single dose control: 30 healthy individuals ingest 500 mg of starch capsule (placebo)
Ex
Dietary supplement
G07.610.593.260
Sponsors
Universidade Federal da Paraíba
Universidade Federal da Paraíba
Eligibility
Inclusion criteria
Inclusion criteria: 90 Individuals of both sexes; aged between 18 and 59 years; healthy self-appointed; residence in João Pessoa-PB, signing the free and informed consent term.
Exclusion criteria
Exclusion criteria: Subjects with any somatic or mental disorder diagnosed; pregnant women; individuals with chronic use of drugs, including drugs / substances that interfere in the degree of anxiety.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes are expected not | — |
Primary
| Measure | Time frame |
|---|---|
| Reducing Anxiety Inventory scores evaluated by trace-state anxiety from the observation of a variation of at least 5% in the measurements between the groups. ;Maintenance of Anxiety Inventory scores evaluated by State-trait anxiety, with no variation of at least 5% in the measurements between the groups. | — |
Countries
Brazil
Contacts
Public ContactJanilson;Janilson da Silva;Silva
Universidade Federal da Paraíba;Universidade Federal da Paraíba
Outcome results
None listed